Ibrutinib selectively targets FLT3-ITD in mutant FLT3-positive AML

H. Wu, C. Hu, A. Wang, E. L. Weisberg, W. Wang, C. Chen, Z. Zhao, K. Yu, J. Liu, J. Wu, A. Nonami, L. Wang, B. Wang, R. M. Stone, S. Liu, J. D. Griffin, J. Liu, Q. Liu

研究成果: ジャーナルへの寄稿レター

13 引用 (Scopus)
元の言語英語
ページ(範囲)754-757
ページ数4
ジャーナルLeukemia
30
発行部数3
DOI
出版物ステータス出版済み - 3 1 2016

Fingerprint

Leukemic Gene Expression Regulation
Heterocyclic Bridged Bicyclo Compounds
fms-Like Tyrosine Kinase 3
Benzamides
Pyrazoles
STAT5 Transcription Factor
Molecular Targeted Therapy
G1 Phase Cell Cycle Checkpoints
Pyrimidines
Proto-Oncogene Proteins c-akt
Organ Specificity
Protein Kinase Inhibitors
Tumor Cell Line
Acute Myeloid Leukemia
Antineoplastic Agents
Protein-Tyrosine Kinases
Signal Transduction
Phosphorylation
Apoptosis
PCI 32765

All Science Journal Classification (ASJC) codes

  • Hematology
  • Oncology
  • Cancer Research

これを引用

Wu, H., Hu, C., Wang, A., Weisberg, E. L., Wang, W., Chen, C., ... Liu, Q. (2016). Ibrutinib selectively targets FLT3-ITD in mutant FLT3-positive AML. Leukemia, 30(3), 754-757. https://doi.org/10.1038/leu.2015.175

Ibrutinib selectively targets FLT3-ITD in mutant FLT3-positive AML. / Wu, H.; Hu, C.; Wang, A.; Weisberg, E. L.; Wang, W.; Chen, C.; Zhao, Z.; Yu, K.; Liu, J.; Wu, J.; Nonami, A.; Wang, L.; Wang, B.; Stone, R. M.; Liu, S.; Griffin, J. D.; Liu, J.; Liu, Q.

:: Leukemia, 巻 30, 番号 3, 01.03.2016, p. 754-757.

研究成果: ジャーナルへの寄稿レター

Wu, H, Hu, C, Wang, A, Weisberg, EL, Wang, W, Chen, C, Zhao, Z, Yu, K, Liu, J, Wu, J, Nonami, A, Wang, L, Wang, B, Stone, RM, Liu, S, Griffin, JD, Liu, J & Liu, Q 2016, 'Ibrutinib selectively targets FLT3-ITD in mutant FLT3-positive AML', Leukemia, 巻. 30, 番号 3, pp. 754-757. https://doi.org/10.1038/leu.2015.175
Wu H, Hu C, Wang A, Weisberg EL, Wang W, Chen C その他. Ibrutinib selectively targets FLT3-ITD in mutant FLT3-positive AML. Leukemia. 2016 3 1;30(3):754-757. https://doi.org/10.1038/leu.2015.175
Wu, H. ; Hu, C. ; Wang, A. ; Weisberg, E. L. ; Wang, W. ; Chen, C. ; Zhao, Z. ; Yu, K. ; Liu, J. ; Wu, J. ; Nonami, A. ; Wang, L. ; Wang, B. ; Stone, R. M. ; Liu, S. ; Griffin, J. D. ; Liu, J. ; Liu, Q. / Ibrutinib selectively targets FLT3-ITD in mutant FLT3-positive AML. :: Leukemia. 2016 ; 巻 30, 番号 3. pp. 754-757.
@article{a20acb3d6f4446d5bb25036856fd952b,
title = "Ibrutinib selectively targets FLT3-ITD in mutant FLT3-positive AML",
author = "H. Wu and C. Hu and A. Wang and Weisberg, {E. L.} and W. Wang and C. Chen and Z. Zhao and K. Yu and J. Liu and J. Wu and A. Nonami and L. Wang and B. Wang and Stone, {R. M.} and S. Liu and Griffin, {J. D.} and J. Liu and Q. Liu",
year = "2016",
month = "3",
day = "1",
doi = "10.1038/leu.2015.175",
language = "English",
volume = "30",
pages = "754--757",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Ibrutinib selectively targets FLT3-ITD in mutant FLT3-positive AML

AU - Wu, H.

AU - Hu, C.

AU - Wang, A.

AU - Weisberg, E. L.

AU - Wang, W.

AU - Chen, C.

AU - Zhao, Z.

AU - Yu, K.

AU - Liu, J.

AU - Wu, J.

AU - Nonami, A.

AU - Wang, L.

AU - Wang, B.

AU - Stone, R. M.

AU - Liu, S.

AU - Griffin, J. D.

AU - Liu, J.

AU - Liu, Q.

PY - 2016/3/1

Y1 - 2016/3/1

UR - http://www.scopus.com/inward/record.url?scp=84959319167&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959319167&partnerID=8YFLogxK

U2 - 10.1038/leu.2015.175

DO - 10.1038/leu.2015.175

M3 - Letter

C2 - 26139428

AN - SCOPUS:84959319167

VL - 30

SP - 754

EP - 757

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 3

ER -